Class information for:
Level 1: VEMURAFENIB//BRAF INHIBITOR//BRAF

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY 2934640
395 3       MELANOMA//DERMATOLOGY//MALIGNANT MELANOMA 32211
256 2             MELANOMA//MALIGNANT MELANOMA//DERMOSCOPY 19608
1305 1                   VEMURAFENIB//BRAF INHIBITOR//BRAF 2744

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 VEMURAFENIB authKW 1564547 8% 62% 219
2 BRAF INHIBITOR authKW 1324684 6% 70% 165
3 BRAF authKW 1041906 14% 24% 378
4 DABRAFENIB authKW 952133 4% 73% 113
5 TRAMETINIB authKW 726661 3% 70% 90
6 MEK INHIBITOR authKW 543463 4% 43% 109
7 MELANOMA authKW 485640 28% 5% 781
8 NRAS authKW 455564 4% 40% 99
9 BRAF V600E authKW 262551 3% 31% 73
10 B RAF authKW 220746 2% 30% 64

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Oncology 28949 53% 0% 1458
2 Dermatology 13635 17% 0% 471
3 Cell Biology 1866 15% 0% 411
4 Chemistry, Medicinal 1304 7% 0% 196
5 Pathology 1132 6% 0% 172
6 Medicine, Research & Experimental 660 7% 0% 191
7 Pharmacology & Pharmacy 336 9% 0% 248
8 Genetics & Heredity 166 5% 0% 129
9 Biochemistry & Molecular Biology 104 10% 0% 275
10 Medical Laboratory Technology 52 1% 0% 27

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 SIGNAL TRANSDUCT TEAM 201184 1% 60% 29
2 MELANOMA MED ONCOL 162735 3% 18% 78
3 MELANOMA AUSTRALIA 124936 1% 27% 40
4 MELANOMA 92012 2% 19% 42
5 CUTANEOUS ONCOL 76813 1% 17% 40
6 GENE ONCOGENE TARGETING TEAM 61242 0% 67% 8
7 MELANOMA MED ONCOL SYST BIOL 57419 0% 100% 5
8 SURG ONCOL MED ONCOL DERMATOL 57419 0% 100% 5
9 WESTMEAD CANC 51543 1% 11% 41
10 FOREMAN FDN MELANOMA 49613 0% 39% 11

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 PIGMENT CELL & MELANOMA RESEARCH 128914 3% 14% 83
2 MELANOMA RESEARCH 37223 3% 4% 77
3 CANCER DISCOVERY 17261 1% 5% 28
4 CLINICAL CANCER RESEARCH 10668 4% 1% 120
5 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 9114 0% 7% 12
6 MOLECULAR CANCER THERAPEUTICS 9110 2% 1% 58
7 CANCER CELL 4850 1% 2% 26
8 JOURNAL OF INVESTIGATIVE DERMATOLOGY 4307 2% 1% 64
9 JAMA DERMATOLOGY 3428 0% 2% 13
10 ONCOTARGET 2965 2% 0% 66

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 VEMURAFENIB 1564547 8% 62% 219 Search VEMURAFENIB Search VEMURAFENIB
2 BRAF INHIBITOR 1324684 6% 70% 165 Search BRAF+INHIBITOR Search BRAF+INHIBITOR
3 BRAF 1041906 14% 24% 378 Search BRAF Search BRAF
4 DABRAFENIB 952133 4% 73% 113 Search DABRAFENIB Search DABRAFENIB
5 TRAMETINIB 726661 3% 70% 90 Search TRAMETINIB Search TRAMETINIB
6 MEK INHIBITOR 543463 4% 43% 109 Search MEK+INHIBITOR Search MEK+INHIBITOR
7 MELANOMA 485640 28% 5% 781 Search MELANOMA Search MELANOMA
8 NRAS 455564 4% 40% 99 Search NRAS Search NRAS
9 BRAF V600E 262551 3% 31% 73 Search BRAF+V600E Search BRAF+V600E
10 B RAF 220746 2% 30% 64 Search B+RAF Search B+RAF

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 31888 ALFA 2B//ANTI TYRP 1 GP75//BLOOD PERFUSION ESTIMATES
2 10196 RAF//KSR1//LEO JENKINS CANC
3 7028 BIOCHEMOTHERAPY//METASTATIC MELANOMA//DACARBAZINE
4 21842 RESEARCH BIOPSY//PRECISION ONCOLOGY//PERSONALIZED CANC THER Y
5 20977 MIR 137//MIR 211//CICATS BIOSTAT
6 255 PD L1//PD 1//IPILIMUMAB
7 17340 PEA 15//ERK2//PROGRAM PHARM
8 30981 DIARYLAMIDE//DNA SYNTHESOME//ARYLCHLOROETHYLUREAS
9 11164 WAARDENBURG SYNDROME//MITF//SOX10
10 26007 CELLULAR HEMOSTASIS//NEVOCELLULAR NEVI//SKIN DIS PROGRAM

Go to start page